Location History:
- Chorlton, GB (2005)
- Manchester, GB (2005)
Company Filing History:
Years Active: 2005
Title: Amjad Nissar Chaudry: Innovator in Infection Detection
Introduction
Amjad Nissar Chaudry is a notable inventor based in Chorlton, GB. He has made significant contributions to the field of medical diagnostics, particularly in the detection of infections. With a total of 2 patents to his name, Chaudry's work is paving the way for advancements in healthcare technology.
Latest Patents
Chaudry's latest patents focus on innovative methods for detecting bacterial vaginosis. One patent discloses a method for detecting the presence of bacterial vaginosis in a female subject. This method involves determining infections in liquid samples by detecting short-chain fatty acids and ammonia in the headspace associated with the liquid sample using polymer sensors. Another patent outlines a method for determining the presence of an infection in a liquid sample. This method includes lowering the pH of the liquid sample to drive short-chain fatty acids, particularly acetic acid, to the gaseous phase. The detection of these compounds, along with ammonia and optionally amine species, is achieved using a detector sensitive to their presence, particularly conductive and semi-conductive polymer sensors. The correlation of these detected substances with the presence of infection is a key aspect of his innovative approach.
Career Highlights
Amjad Nissar Chaudry is currently associated with Osmetech Plc, where he continues to develop and refine his inventions. His work is instrumental in enhancing diagnostic methods that can lead to better patient outcomes.
Collaborations
Chaudry collaborates with notable professionals in his field, including Paul James Travers and Andrew John Tummon. Their combined expertise contributes to the advancement of medical technology and innovation.
Conclusion
Amjad Nissar Chaudry is a pioneering inventor whose work in infection detection is making a significant impact in the medical field. His innovative patents and collaborations are setting new standards for diagnostic methods.